Temporal glioblastoma presenting as catatonia.
cns cancer
depressive disorder
Journal
BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291
Informations de publication
Date de publication:
04 Mar 2019
04 Mar 2019
Historique:
entrez:
7
3
2019
pubmed:
7
3
2019
medline:
20
6
2019
Statut:
epublish
Résumé
The objective of this article is to describe the possible association of catatonia and temporal brain lesions. This is a case presentation of a 57-year-old man presenting with depression, with catatonia secondary to a temporal glioblastoma. He was referred to hospital because for a sudden deterioration in depressed state. He was diagnosed with catatonia and treated successfully with lorazepam. During his admission, he became increasingly disinhibited, and an MRI scan revealed an intracranial mass in the right temporal lobe, with uncal herniation and a mass effect. Surgical resection of the entire tumour was successful. Histological examination revealed a glioblastoma multiforme requiring additional chemoradiotherapy. Postoperatively, catatonic signs and symptoms were not detectable. A postsurgical frontal syndrome with disinhibition and logorrhoea was present and gradually normalised over the course of several weeks. Catatonia can be the presenting symptom of a temporal brain tumour, and should therefore prompt the physician to a thorough medical investigation.
Identifiants
pubmed: 30837231
pii: 12/3/e224017
doi: 10.1136/bcr-2017-224017
pmc: PMC6424181
pii:
doi:
Substances chimiques
Anti-Anxiety Agents
0
Lorazepam
O26FZP769L
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Acta Psychiatr Scand. 2016 Mar;133(3):250-1
pubmed: 26426740
Schizophr Bull. 2004;30(2):405-27
pubmed: 15279056
Int J Cancer. 2009 Jun 15;124(12):2917-22
pubmed: 19330831
Acta Neurochir (Wien). 2016 Sep;158(9):1669-82
pubmed: 27318813
Neurosurgery. 2004 Feb;54(2):358-66; discussion 366-7
pubmed: 14744282
Psychooncology. 2002 May-Jun;11(3):230-8
pubmed: 12112483
Tijdschr Psychiatr. 2015;57(2):99-103
pubmed: 25669946
J Neurooncol. 2009 Sep;94(2):153-61
pubmed: 19262993
J Psychiatr Res. 2009 Mar;43(6):607-14
pubmed: 18951556
Indian J Psychiatry. 2000 Oct;42(4):327-46
pubmed: 21407969
CNS Spectr. 2016 Aug;21(4):341-8
pubmed: 27255726
Vertex. 2012 Jul-Aug;23(104):312-20
pubmed: 23170304
J Clin Oncol. 2009 Mar 20;27(9):1440-5
pubmed: 19224839
Cancer Imaging. 2009 Oct 02;9 Spec No A:S10-3
pubmed: 19965288
Epilepsy Behav. 2010 Nov;19(3):528-32
pubmed: 20817612
Neuropsychiatr Dis Treat. 2015 Jun 10;11:1413-20
pubmed: 26089669
J ECT. 2010 Dec;26(4):253-8
pubmed: 21076339
World J Biol Psychiatry. 2007;8(1):54-5
pubmed: 17366353
J Neuropsychiatry Clin Neurosci. 2016 Spring;28(2):124-30
pubmed: 26670787
Expert Rev Neurother. 2010 Oct;10(10):1529-36
pubmed: 20925469
Front Psychiatry. 2014 Dec 09;5:181
pubmed: 25538636
J Neuropsychiatry Clin Neurosci. 2010 Summer;22(3):352k.e17-352.e17
pubmed: 20686155
Neuropsychobiology. 1996;34(2):76-81
pubmed: 8904736
CNS Spectr. 2006 Jan;11(1):28-31
pubmed: 16400253
J Clin Psychiatry. 1981 Sep;42(9):352-3
pubmed: 7275942
Am J Psychiatry. 1962 Nov;119:451-5
pubmed: 13978428
J Natl Cancer Inst. 2011 Jan 5;103(1):61-76
pubmed: 21106962
J Neurosurg. 2008 Feb;108(2):281-6
pubmed: 18240923
Psychosomatics. 1986 Dec;27(12):860-2
pubmed: 3809383
Acta Psychiatr Scand. 1996 Feb;93(2):137-43
pubmed: 8686484
J Clin Oncol. 2011 Nov 10;29(32):4307-12
pubmed: 21990406
Expert Rev Neurother. 2007 Apr;7(4):343-9
pubmed: 17425489
Cogn Behav Neurol. 2007 Dec;20(4):232-4
pubmed: 18091073